Mary Coelho
Directeur Financier/CFO chez GAMIDA CELL LTD.
Fortune : 55 388 $ au 30/04/2024
Postes actifs de Mary Coelho
Sociétés | Poste | Début | Fin |
---|---|---|---|
ENTERO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2021 | - |
Independent Dir/Board Member | 11/08/2021 | - | |
HOOKIPA PHARMA INC. | Directeur/Membre du Conseil | 03/04/2023 | - |
Independent Dir/Board Member | 03/04/2023 | - | |
GAMIDA CELL LTD. | Comptroller/Controller/Auditor | 22/05/2023 | - |
Directeur Financier/CFO | 22/05/2023 | - | |
INOTIV, INC. | Directeur/Membre du Conseil | 16/10/2023 | - |
Independent Dir/Board Member | 16/10/2023 | - |
Historique de carrière de Mary Coelho
Anciens postes connus de Mary Coelho
Sociétés | Poste | Début | Fin |
---|---|---|---|
CINCOR PHARMA, INC. | Directeur Financier/CFO | 01/11/2021 | 04/11/2022 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur Financier/CFO | 15/01/2019 | 03/11/2021 |
Investor Relations Contact | - | 03/11/2021 | |
Treasurer | 15/01/2019 | 03/11/2021 | |
BALCHEM CORPORATION | Directeur Financier/CFO | 23/10/2017 | 26/10/2018 |
Treasurer | 23/10/2017 | 26/10/2018 | |
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Directeur des opérations | 01/09/2017 | 01/10/2017 |
Directeur Financier/CFO | 01/10/2014 | 01/09/2017 | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2007 | 01/10/2014 |
░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mary Coelho
School of International Service | Undergraduate Degree |
Ibmec Business School | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 11 |
Brésil | 2 |
Israël | 2 |
Opérationnelle
Director of Finance/CFO | 5 |
Director/Board Member | 3 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 7 |
Consumer Non-Durables | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 5 |
---|---|
BALCHEM CORPORATION | Consumer Non-Durables |
ENTERO THERAPEUTICS, INC. | Health Technology |
HOOKIPA PHARMA INC. | Health Technology |
GAMIDA CELL LTD. | Health Technology |
INOTIV, INC. | Commercial Services |
Entreprise privées | 5 |
---|---|
Diversey, Inc.
Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Consumer Non-Durables |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Mars, Inc.
Mars, Inc. Food: Specialty/CandyConsumer Non-Durables Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA. | Consumer Non-Durables |
CinCor Pharma, Inc.
CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Mary Coelho
- Expérience